Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 26-Jan-24 4:36 PM View:  | Doebele Robert See Remarks | Rain Oncology Inc. (RAIN) | 26-Jan-24 | Disposition (change in control) | 476,827 | -- | -- | (100%) 476.83K to 0 | |
| 26-Jan-24 4:34 PM View: | Vellanki Avanish Chairman and CEO Director | Rain Oncology Inc. (RAIN) | 26-Jan-24 | Disposition (change in control) | 2,550,910 | -- | -- | (100%) 2.55M to 0 | |
| 26-Jan-24 4:49 PM View: | Radovich Peter Director | Rain Oncology Inc. (RAIN) | 26-Jan-24 | Disposition (change in control) | 8,796 | -- | -- | (100%) 8.8K to 0 | |
| 26-Jan-24 4:39 PM View: | Berger Franklin M Director | Rain Oncology Inc. (RAIN) | 26-Jan-24 | Disposition (change in control) | 1,005,210 | -- | -- | (100%) 1.01M to 0 | |
| 26-Jan-24 4:41 PM View: | Davis Aaron I. Director | Rain Oncology Inc. (RAIN) | 26-Jan-24 | Disposition (change in control) | 79,726 | -- | -- | (100%) 79.73K to 0 | |
| 02-Feb-24 4:00 PM View: | Tang Kevin C 10% Owner | Rain Oncology Inc. (RAIN) | 26-Jan-24 | Disposition (change in control) | 3,850,510 | -- | -- | (100%) 3.85M to 0 | |
| 29-Jan-24 8:40 PM View: | Bvf Partners L P/il Director | Rain Oncology Inc. (RAIN) | 25-Jan-24 | Disposition (change in control) | 8,576,800 | -- | -- | (100%) 8.58M to 0 | |
| 18-Dec-23 6:29 PM View: | Tang Kevin C 10% Owner | Rain Oncology Inc. (RAIN) | 18-Dec-23 | Sale | 40,132 | $1.21 | $48,559.70 | (1%) 3.89M to 3.85M | |
| 18-Dec-23 6:29 PM View: | Tang Kevin C 10% Owner | Rain Oncology Inc. (RAIN) | 15-Dec-23 | Sale | 109,435 | $1.20 | $131,322.00 | (3%) 4.0M to 3.89M | |
| 18-Dec-23 6:29 PM View: | Tang Kevin C 10% Owner | Rain Oncology Inc. (RAIN) | 14-Dec-23 | Sale | 24,406 | $1.21 | $29,531.30 | (< 1%) 4.02M to 4.0M | |
| 13-Oct-23 4:57 PM View: | Tang Kevin C 10% Owner | Rain Oncology Inc. (RAIN) | 13-Oct-23 | Purchase | 131,631 | $0.99 | $130,315.00 | 3% 3.89M to 4.02M | |
| 13-Oct-23 4:57 PM View: | Tang Kevin C 10% Owner | Rain Oncology Inc. (RAIN) | 12-Oct-23 | Purchase | 77,702 | $0.98 | $76,148.00 | 2% 3.82M to 3.89M | |
| 13-Oct-23 4:57 PM View: | Tang Kevin C 10% Owner | Rain Oncology Inc. (RAIN) | 11-Oct-23 | Private Purchase | 74,812 | $0.97 | $72,567.60 | 2% 3.74M to 3.82M | |
| 01-Jun-23 6:46 PM View: | Tang Kevin C 10% Owner | Rain Oncology Inc. (RAIN) | 01-Jun-23 | Purchase | 333,325 | $1.11 | $370,534.00 | 10% 3.41M to 3.74M | |
| 01-Jun-23 6:46 PM View: | Tang Kevin C 10% Owner | Rain Oncology Inc. (RAIN) | 31-May-23 | Purchase | 166,180 | $1.08 | $179,574.00 | 5% 3.24M to 3.41M | |
| 01-Jun-23 6:46 PM View: | Tang Kevin C 10% Owner | Rain Oncology Inc. (RAIN) | 30-May-23 | Private Purchase | 588,768 | $1.03 | $608,655.00 | 22% 2.65M to 3.24M | |
| 24-May-23 8:05 PM View: | Boxer Capital, LLC | Rain Oncology Inc. (RAIN) | 22-May-23 | Sale | 995,000 | $1.25 | $1,243,750.00 | (46%) 2.15M to 1.15M | |
| 23-Nov-22 5:45 PM View: | Berger Franklin M Director | Rain Oncology Inc. (RAIN) | 22-Nov-22 | Purchase | 77,000 | $8.27 | $636,790.00 | 8% 928.21K to 1.01M | |
| 23-Nov-22 5:45 PM View: | Berger Franklin M Director | Rain Oncology Inc. (RAIN) | 21-Nov-22 | Private Purchase | 45,000 | $7.80 | $351,000.00 | 5% 883.21K to 928.21K | |
| 14-Nov-22 4:17 PM View: | Berger Franklin M Director | Rain Oncology Inc. (RAIN) | 08-Nov-22 | Private Purchase | 42,881 | $5.83 | $249,996.00 | 5% 840.33K to 883.21K | |
| 10-Nov-22 6:31 PM View: | Bvf Partners L P/il Director 10% Owner | Rain Oncology Inc. (RAIN) | 08-Nov-22 | Private Purchase | 1,710,360 | $5.83 | $9,971,390.00 | 25% 6.87M to 8.58M | |
| 08-Nov-22 4:30 PM View: | Davis Aaron I. Director | Rain Oncology Inc. (RAIN) | 04-Nov-22 | Private Purchase | 972,212 | $5.83 | $5,668,000.00 | 83% 1.17M to 2.15M | |
| 07-Jul-22 6:02 PM View: | Doebele Robert See Remarks | Rain Oncology Inc. (RAIN) | 06-Jul-22 | Option Exercise | 3,890 | $3.95 | $15,365.50 | < 1% 472.94K to 476.83K | |
| 02-Jun-22 4:05 PM View: | Vellanki Avanish Chairman and CEO Director 10% Owner | Rain Oncology Inc. (RAIN) | 01-Jun-22 | Private Purchase | 25,000 | $2.29 | $57,250.00 | 1% 2.45M to 2.47M | |
| 15-Apr-22 4:30 PM View: | Vellanki Avanish Chairman and CEO Director 10% Owner | Rain Oncology Inc. (RAIN) | 14-Apr-22 | Gift | 59,618 | -- | -- | 2% 2.53M to 2.59M | |
| 15-Apr-22 4:30 PM View: | Vellanki Avanish Chairman and CEO Director 10% Owner | Rain Oncology Inc. (RAIN) | 14-Apr-22 | Gift | 59,618 | -- | -- | (2%) 2.59M to 2.53M | |
| 15-Apr-22 4:30 PM View: | Doebele Robert See Remarks | Rain Oncology Inc. (RAIN) | 13-Apr-22 | Option Exercise | 3,000 | $3.95 | $11,850.00 | < 1% 469.94K to 472.94K | |
| 04-Apr-22 4:15 PM View: | Doebele Robert See Remarks | Rain Oncology Inc. (RAIN) | 31-Mar-22 | Option Exercise | 2,000 | $3.95 | $7,900.00 | < 1% 467.94K to 469.94K | |
| 15-Mar-22 3:23 PM View: | Vellanki Avanish President and CEO Director | Rain Oncology Inc. (RAIN) | 11-Mar-22 | Option Exercise | 14,468 | $4.00 | $57,872.00 | < 1% 2.96M to 2.98M | |
| 10-Jan-22 6:03 PM View: | Bvf Partners L P/il Director 10% Owner | Rain Oncology Inc. (RAIN) | 07-Jan-22 | Market Purchase | 496,385 | $12.00 | $5,956,620.00 | 8% 6.37M to 6.87M | < 1% |
| 10-Jan-22 6:03 PM View: | Bvf Partners L P/il Director 10% Owner | Rain Oncology Inc. (RAIN) | 06-Jan-22 | Market Purchase | 61,343 | $12.00 | $736,018.00 | < 1% 6.31M to 6.37M | < 1% |
| 13-Oct-21 5:47 PM View: | Perceptive Advisors LLC 10% Owner | Rain Oncology Inc. (RAIN) | 12-Oct-21 | Market Sale | 7,306 | $13.40 | $97,900.40 | (< 1%) 2.49M to 2.49M | (1%) |
| 13-Oct-21 5:47 PM View: | Perceptive Advisors LLC 10% Owner | Rain Oncology Inc. (RAIN) | 11-Oct-21 | Market Sale | 21,826 | $12.51 | $273,040.00 | (< 1%) 2.52M to 2.49M | (8%) |
| 13-Oct-21 5:47 PM View: | Perceptive Advisors LLC 10% Owner | Rain Oncology Inc. (RAIN) | 08-Oct-21 | Market Sale | 7,500 | $13.15 | $98,621.10 | (< 1%) 2.52M to 2.52M | (3%) |
| 13-Oct-21 5:47 PM View: | Perceptive Advisors LLC 10% Owner | Rain Oncology Inc. (RAIN) | 07-Oct-21 | Market Sale | 13,368 | $14.81 | $197,918.00 | (< 1%) 2.54M to 2.52M | 8% |
| 23-Sep-21 10:00 PM View: | Berger Franklin M Director | Rain Oncology Inc. (RAIN) | 21-Sep-21 | Market Purchase | 3,786 | $14.30 | $54,139.80 | < 1% 836.54K to 840.33K | 5% |
| 23-Sep-21 10:00 PM View: | Bvf Partners L P/il Director 10% Owner | Rain Oncology Inc. (RAIN) | 21-Sep-21 | Market Purchase | 11,033 | $13.94 | $153,829.00 | < 1% 6.3M to 6.31M | 8% |
| 15-Sep-21 5:23 PM View: | Bvf Partners L P/il Director 10% Owner | Rain Oncology Inc. (RAIN) | 13-Sep-21 | Market Purchase | 392,269 | $16.49 | $6,468,520.00 | 7% 5.91M to 6.3M | (1%) |
| 06-Jul-21 7:34 PM View: | Bvf Partners L P/il Director 10% Owner | Rain Oncology Inc. (RAIN) | 06-Jul-21 | Market Purchase | 269,723 | $15.25 | $4,113,280.00 | 5% 5.64M to 5.91M | 4% |
| 06-Jul-21 7:34 PM View: | Bvf Partners L P/il Director 10% Owner | Rain Oncology Inc. (RAIN) | 01-Jul-21 | Market Purchase | 317,279 | $15.65 | $4,965,420.00 | 6% 5.32M to 5.64M | 1% |
| 25-May-21 8:31 PM View: | Bvf Partners L P/il Director 10% Owner | Rain Oncology Inc. (RAIN) | 24-May-21 | Market Purchase | 1,361 | $15.90 | $21,633.40 | < 1% 5.32M to 5.32M | 9% |
| 25-May-21 8:31 PM View: | Bvf Partners L P/il Director 10% Owner | Rain Oncology Inc. (RAIN) | 21-May-21 | Market Purchase | 121,986 | $15.94 | $1,944,700.00 | 2% 5.2M to 5.32M | 9% |
| 20-May-21 7:18 PM View: | Bvf Partners L P/il Director | Rain Oncology Inc. (RAIN) | 19-May-21 | Market Purchase | 17,268 | $15.88 | $274,290.00 | < 1% 5.18M to 5.2M | 3% |
| 20-May-21 7:18 PM View: | Bvf Partners L P/il Director | Rain Oncology Inc. (RAIN) | 18-May-21 | Market Purchase | 191,197 | $16.65 | $3,183,430.00 | 4% 4.99M to 5.18M | (2%) |
| 17-May-21 8:43 PM View: | Bvf Partners L P/il Director | Rain Oncology Inc. (RAIN) | 13-May-21 | Market Purchase | 58,000 | $14.26 | $827,167.00 | 1% 4.93M to 4.99M | 7% |
| 27-Apr-21 5:07 PM View: | Radovich Peter Director | Rain Oncology Inc. (RAIN) | 27-Apr-21 | Conversion | 8,796 | -- | -- | 100% 0 to 8.8K | |
| 27-Apr-21 5:09 PM View: | Davis Aaron I. Director 10% Owner | Rain Oncology Inc. (RAIN) | 27-Apr-21 | Market Purchase Duplicate | 1,025,000 | $17.00 | $17,425,000.00 | 683% 150.0K to 1.18M | |
| 27-Apr-21 7:30 PM View: | Perceptive Advisors LLC 10% Owner | Rain Oncology Inc. (RAIN) | 27-Apr-21 | Conversion | 1,987,020 | -- | -- | 100% 0 to 1.99M | |
| 29-Apr-21 4:02 PM View: | Cormorant Asset Management,... | Rain Oncology Inc. (RAIN) | 27-Apr-21 | Conversion | 2,326,660 | -- | -- | 100% 2.33M to 4.65M | |
| 27-Apr-21 5:04 PM View: | Doebele Robert EVP, Chief Scientific Officer | Rain Oncology Inc. (RAIN) | 27-Apr-21 | Conversion | 4,932 | -- | -- | 1% 463.0K to 467.94K |
